Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4189678, 7 pages
https://doi.org/10.1155/2017/4189678
Clinical Study

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers

1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China
3Department of Pediatrics, Xiangya Hospital, Central South University, Changsha 410008, China
4Department of Neurology, Xiangya Hospital, Central South University, Changsha 410078, China
5Tang Center for Herbal Medicine Research, The Pritzker School of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4028, Chicago, IL 60637, USA

Correspondence should be addressed to Wei-Hua Huang and Zhi-Rong Tan

Received 31 August 2016; Revised 1 November 2016; Accepted 17 November 2016; Published 26 February 2017

Academic Editor: Heiko Reutter

Copyright © 2017 Yong-Jun Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yong-Jun Tang, Kai Hu, Wei-Hua Huang, et al., “Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers,” BioMed Research International, vol. 2017, Article ID 4189678, 7 pages, 2017. doi:10.1155/2017/4189678